Skip to main content
SpringerLink
Log in

Chronic Hepatitis B

  • Chapter
  • First Online:
Liver Disease in Clinical Practice

Part of the book series: In Clinical Practice ((ICP))

  • 1357 Accesses

Abstract

A 45-year-old male Chinese university lecturer presented to his GP with malaise and dark urine. He was referred to the local infectious diseases clinic, and blood tests were as follows:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Blumberg BS, Alter HJ, Visnich S. A “New” antigen in leukemia sera. JAMA. 1965;191:541–6.

    Article  CAS  PubMed  Google Scholar 

  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.

    Article  PubMed  Google Scholar 

  3. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582–92.

    Article  CAS  PubMed  Google Scholar 

  4. Martinot-Peignoux M, Lapalus M, Asselah T, Marcellin P. HBsAg quantification: useful for monitoring natural history and treatment outcome. Liver Int Off J Int Assoc Study Liver. 2014;34 Suppl 1:97–107.

    CAS  Google Scholar 

  5. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012;1:e00049.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rehermann B. Natural killer cells in viral hepatitis. Cell Mol Gastroenterol Hepatol. 2015;1(6):578–88.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bertoletti A, Kennedy PT. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept. Cell Mol Immunol. 2015;12(3):258–63.

    Article  CAS  PubMed  Google Scholar 

  8. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):65–73.

    Article  CAS  PubMed  Google Scholar 

  9. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347(3):168–74.

    Article  CAS  PubMed  Google Scholar 

  10. Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Batrla-Utermann R, et al. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma. Gut. 2014;63(10):1648–57.

    Article  CAS  PubMed  Google Scholar 

  11. Gill US, Zissimopoulos A, Al-Shamma S, Burke K, McPhail MJ, Barr DA, et al. Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk? J Infect Dis. 2015;211(3):374–82.

    Article  CAS  PubMed  Google Scholar 

  12. Tsai NC, Marcellin P, Buti M, Washington MK, Lee SS, Chan S, et al. Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B. Dig Dis Sci. 2015;60(1):260–8.

    Article  CAS  PubMed  Google Scholar 

  13. Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381(9865):468–75.

    Article  CAS  PubMed  Google Scholar 

  14. Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol. 2015;62(4):956–67.

    Article  PubMed  Google Scholar 

  15. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261–83.

    Article  PubMed  Google Scholar 

  16. European Association For The Study Of The L. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167–85.

    Article  Google Scholar 

  17. Sarri G, Westby M, Bermingham S, Hill-Cawthorne G, Thomas H, Guideline Development G. Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance. BMJ. 2013;346:f3893.

    Article  PubMed  Google Scholar 

  18. Sonneveld MJ, Rijckborst V, Boucher CA, Hansen BE, Janssen HL. Prediction of sustained response to peg interferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline. Hepatology. 2010;52(4):1251–7.

    Article  CAS  PubMed  Google Scholar 

  19. Zoulim F, Mason WS. Reasons to consider earlier treatment of chronic HBV infections. Gut. 2012;61(3):333–6.

    Article  CAS  PubMed  Google Scholar 

  20. Thimme R, Dandri M. Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B? J Hepatol. 2013;58(2):205–9.

    Article  PubMed  Google Scholar 

  21. Yang N, Bertoletti A. Advances in therapeutics for chronic hepatitis B. Hepatol Int. 2016;10(2):277–85.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Blizard Institute, Barts and The London SMD, QMUL, Newark St, London, E1 2AT, UK

    Navjyot Hansi (Clinical Research Fellow) & Upkar Gill

  2. Reader in Hepatology, Blizard Institute, Barts and The London SMD, QMUL, Newark St, London, E1 2AT, UK

    Patrick Kennedy

Authors
  1. Navjyot Hansi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Upkar Gill
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick Kennedy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick Kennedy .

Editor information

Editors and Affiliations

  1. Royal Liverpool University Hospital, Liverpool, Merseyside, United Kingdom

    Tim Cross

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hansi, N., Gill, U., Kennedy, P. (2017). Chronic Hepatitis B. In: Cross, T. (eds) Liver Disease in Clinical Practice. In Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-43126-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43126-0_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43125-3

  • Online ISBN: 978-3-319-43126-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation